Sfoglia per Autore
Low rate of S gene mutants in transplantated patients is associated to a maintained HBIG response even in the presence of YMDD mutants
2002 R. Romeo, L. Caccamo, G. Rossi, F. Facchetti, L. Fassati, M. Colombo
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population
2003 T. M. Neri, G. M. Cavestro, P. Seghini, P. F. Zanelli, A. Zanetti, M. Savi, M. Podda, M. Zuin, M. Colombo, A. Floreani, F. Rosina, G. Bianchi Porro, M. Strazzabosco, L. Okolicsanyi
Long-term suppression of hepatitis B e antigen negative chronic hepatitis B by 24 month interferon therapy
2003 P. Lampertico, E. Del Ninno, M. Viganò, R. Romeo, M.F. Donato, E. Sablon, A. Morabito, M. Colombo
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey
2003 L. Okolicsanyi, M. Groppo, A. Floreani, A. M. Morselli-Labate, A. G. Rusticali, A. Battocchia, M. Colombo, G. Galatola, G. Gasbarrini, M. Podda, G. Ricci, F. Rosina, M. Zuin
Total HCV core antigen assay : a new marker of hepatitis C viremia for monitoring the progress of therapy
2003 A.R. Zanetti, L. Romanò, M. Brunetto, M. Colombo, G. Bellati, C. Tackney
The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma
2003 M. Iavarone, P. Lampertico, C. Seletti, M.F. Donato, G. Ronchi, E. Del Ninno, M. Colombo
Pre-transplant YMDD mutants without HBV recurrence in viremic liver graft recipients given continuos combined lavimudine/immunoprophylaxis
2003 L. Caccamo, R. Romeo, G. Rossi, P. Reggiani, M. Colombo, L.R. Fassati
Interferon Therapy in Hepatitis B e Antigen-Negative Chronic Hepatitis B : reply
2003 P. Lampertico, M. Colombo
A prospective study of peripheral blood alpha-fetoprotein messenger RNA in cirrhotic patients at risk of hepatocellular carcinoma
2003 M. Iavarone, P. Lampertico, G. Ronchi, E. Del Ninno, A. Zanella, M. Colombo
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection
2003 G.B. Gaeta, G. Stornaiuolo, D.F. Precone, S. Lobello, M. Chiaramonte, T. Stroffolini, G. Colucci, M. Rizzetto, A. Craxı̀, V. Di Marco, G. Raimondo, G. Pastore, T. Santantonio, P. Dentico, F. Piccinino, M. Stanzione, G. Giusti, G. Pilleri, R. Ganga, G. Taliani, C. De Bac, M.R. Brunetto, G. Colloredo Mels, M. Colombo, P. Lampertico
Serum levels of hepatitis C virus core antigen as a markers of infection and response to therapy
2004 R. Soffredini, M. Rumi, M.L. Parravicini, G. Ronchi, E. Del Ninno, A. Russo, M. Colombo
The strategic role of staging in the treatment of HCC
2004 M. Colombo, A. Sangiovanni
Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients
2004 E. Santagostino, F. De Filippi, M. Rumi, M. Rivi, M. Colombo, P.M. Mannucci
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance
2004 A. Sangiovanni, E. Del Ninno, P. Fasani, C. De Fazio, G. Ronchi, R. Romeo, A. Morabito, R. de Franchis, M. Colombo
Hepatitis C in haemophilia : lights and shadows
2004 M.G. Rumi, F. De Filippi, E. Santagostino, M. Colombo
Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis
2004 C. de Lalla, G. Galli, L. Aldrighetti, R. Romeo, M. Mariani, A. Monno, S. Nuti, M. Colombo, F. Callea, S.A. Porcelli, P. Panina-Bordignon, S. Abrignani, G. Casorati, P. Dellabona
Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1b chronic hepatitis C : A randomized controlled trial
2004 S. Bruno, C. Cammà, V. Di Marco, M. Rumi, M. Vinci, M. Camozzi, C. Rebucci, D. Di Bona, M. Colombo, A. Craxi, M.U. Mondelli, G. Pinzello
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
2004 V. Di Marco, A. Marzano, P. Lampertico, P. Andreone, T. Santantonio, P.L. Almasio, M. Rizzetto, A. Craxì, G. Raimondo, G. Squadrito, A. Spadaro, O. Ferrah, T. Santantonio, G. Pastore, G. Niro, A. Andriulli, G. Stornaiolo, M. Stanzione, G.B. Gaeta, F. Piccinino, A. Marrone, G. Ruggiero, R. Ganga, M. Bernas coni, G. Pilleri, M. Brunetto, B. Coco, F. Bonino, G. Mazzella, F. Lodato, P. Andreone, C. Cursaro, s. Fiorino, A.G. Gramenzi, M. Massari, F. Torre, M. Basso, A. Picciotto, S. Targhetta, P. Burra, V. Ciappina, E. Mazzeffini, R. Bruno, S. Bruno, M. Vigano, M. Iavarone, E. Del Ninno, M. Colombo, A. Casella, M. Sonzogni, G. Colloredo, S. Rossi, M. Puoti, S. Gaia, V. Barbon, M. Lagget
Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma
2005 P. Lampertico, M. Vigano, E. Manenti, M.A. Iavarone, G. Lunghi, M. Colombo
Il trattamento dell’epatite virale C
2005 M. Colombo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile